Login Register Cart 0
Generic placeholder image

Current Diabetes Reviews

Editor-in-Chief

ISSN (Print): 1573-3998
ISSN (Online): 1875-6417

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Mini-Review Article

Novel Approaches to Control Diabetes

Author(s): Malissa Mathew Dmello* and Geeta Bhagwat

Volume 20, Issue 5, 2024

Published on: 16 October, 2023

Article ID: e090823219599 Pages: 15

DOI: 10.2174/1573399820666230809152742

Price: $65

Abstract

Diabetes is a chronic, long-term, incurable, but controllable condition. Diabetes mellitus (DM) is a group of metabolic disorders characterized by hyperglycemia that results from defects in insulin secretion, insulin action, or both. People who have diabetes often experience a variety of symptoms, including blurry vision, excessive thirst, fatigue, frequent urination, hunger, and weight loss. This review article includes a discussion on diabetes types, symptoms, diagnostic tests, and various therapies for treating, controlling, and managing blood glucose levels, with a focus on its most recent innovation of therapies and medications. Diabetes management will also be reviewed, along with clinical pharmacodynamics, bioavailability, advantages, and complications of combined drugs/medications.

[1]
Ribeiro C, Mota CSA, Voltarelli FA, de Araújo MB, Botezelli JD. Effects of Moderate Intensity physical training in neonatal alloxan administered rats. J Diabetes Metab 2010; 1(2)
[http://dx.doi.org/10.4172/2155-6156.1000107]
[2]
Silva SB, Costa JP, Pintado ME, Ferreira DC, Sarmento B. Antioxidants in the prevention and treatment of diabetic retinopathy – A review. J Diabetes Metab 2010; 1(3)
[http://dx.doi.org/10.4172/2155-6156.1000111]
[3]
Robertson GL. Diabetes Insipidus Endocrinol Metabol Clin North America 1995; 24(3): 549-72.
[http://dx.doi.org/10.1016/S0889-8529(18)30031-8]
[4]
Christ-Crain M, Gaisl O. Diabetes insipidus. Presse Med 2021; 50(4): 104093.
[http://dx.doi.org/10.1016/j.lpm.2021.104093] [PMID: 34718110]
[5]
Divers J, Mayer-Davis EJ, Lawrence JM, et al. Trends in incidence of type 1 and type 2 diabetes among youths — selected counties and Indian reservations, united states, 2002–2015. Morb Mortal Wkly Rep 2020; 69(6): 161-5.
[http://dx.doi.org/10.15585/mmwr.mm6906a3] [PMID: 32053581]
[6]
Howell SL. The mechanism of insulin secretion. Diabetologia 1984; 26: 319-27.
[7]
DeFronzo RA, Ferrannini E, Groop L, et al. Type 2 diabetes mellitus. Nat Rev Dis Primers 2015; 1(1): 15019.
[http://dx.doi.org/10.1038/nrdp.2015.19] [PMID: 27189025]
[8]
Uppu RM, Parinandi NL. Insulin sensitization and resistance interrelationship revisited with a quantitative molecular model approach. J Diabetes Metab 2011; 02(05)
[http://dx.doi.org/10.4172/2155-6156.1000106e]
[9]
Katsarou A, Gudbjörnsdottir S, Rawshani A, et al. Type 1 diabetes mellitus. Nat Rev Dis Primers 2017; 3(1): 17016.
[http://dx.doi.org/10.1038/nrdp.2017.16] [PMID: 28358037]
[10]
Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet 2017; 389(10085): 2239-51.
[http://dx.doi.org/10.1016/S0140-6736(17)30058-2] [PMID: 28190580]
[11]
Type 2 Diabetes Mellitus, Diagnosis, Adult What are the signs or symptoms? 2017. Available From: www.diabeteseducator.org/patient-resources
[12]
Mungrue K, Roper LA, Chung T. Assessment of weight loss in the management of patients with type 2 diabetes mellitus in primary care in trinidad. J Diabetes Metab 2011; 2(2)
[http://dx.doi.org/10.4172/2155-6156.1000120]
[13]
Lyssenko V, Groop L, Prasad RB. Genetics of Type 2 Diabetes: It matters from which parent we inherit the risk. Rev Diabet Stud 2015; 12(3-4): 233-42.
[http://dx.doi.org/10.1900/RDS.2015.12.233] [PMID: 27111116]
[14]
Lemos Costa TMR. Glycemic variability and mean weekly glucose in the evaluation and treatment of blood glucose in gestational diabetes mellitus; evidence for lower neonatal complications. J Diabetes Metab 2011; 2(5)
[http://dx.doi.org/10.4172/2155-6156.1000137]
[15]
C M. P NP. A review article-gestational diabetes mellitus. Int J Curr Pharm Res 2016; 9(1): 1.
[http://dx.doi.org/10.22159/ijcpr.2017v9i1.16615]
[16]
Skoczek D, Dulak J, Kachamakova-Trojanowska N. Maturity onset diabetes of the young—new approaches for disease modelling. Int J Mol Sci 2021; 22(14): 7553.
[http://dx.doi.org/10.3390/ijms22147553] [PMID: 34299172]
[17]
Naylor R, Knight Johnson A, del Gaudio D. Maturity-onset diabetes of the young overview. rockville pike: National Library of Medicine 1993.
[18]
Beltrand J, Busiah K, Vaivre-Douret L, et al. Neonatal diabetes mellitus. Front Pediatr 2020; 8: 540718.
[http://dx.doi.org/10.3389/fped.2020.540718] [PMID: 33102403]
[19]
Temple IK, Gardner RJ, Mackay DJG, Barber JCK, Robinson DO, Shield JPH. Transient neonatal diabetes widening the understanding of the etiopathogenesis of diabetes. Diabetes 2000; 49(8): 1359-66.
[http://dx.doi.org/10.2337/diabetes.49.8.1359]
[20]
Lemelman MB, Letourneau L, Greeley SAW. Neonatal diabetes mellitus. Clin Perinatol 2018; 45(1): 41-59.
[http://dx.doi.org/10.1016/j.clp.2017.10.006] [PMID: 29406006]
[21]
Khetan AK, Rajagopalan S. Prediabetes. Can J Cardiol 2018; 34(5): 615-23.
[http://dx.doi.org/10.1016/j.cjca.2017.12.030] [PMID: 29731022]
[22]
Good to Know: diabetes symptoms and tests. Clin Diabetes 2020; 38(1): 108-8.
[http://dx.doi.org/10.2337/cd20-pe01] [PMID: 31975760]
[23]
Hansen BC, Shamekh R, Hansson O. The rhesus monkey: A nonhuman primate model for T2DM- associated gene screening. J Diabetes Metab 2011; 02(07)
[http://dx.doi.org/10.4172/2155-6156.1000150]
[24]
Rawal G, Yadav S, Kumar R, Singh A. Glycosylated hemoglobin (HbA1C): A brief overview for clinicians. Indian J Immunol Respirat Med 2016; 1(2): 33-6.
[25]
Alsever RN. Insulinoma with low circulating insulin levels.-the diagnostic value of proinsulin measurements. Ann Intern Med 82(3): 347-50.
[http://dx.doi.org/10.7326/0003-4819-82-3-347]
[26]
Rhee MK, Ho YL, Raghavan S, et al. Random plasma glucose predicts the diagnosis of diabetes. PLoS One 2019; 14(7): e0219964.
[http://dx.doi.org/10.1371/journal.pone.0219964] [PMID: 31323063]
[27]
Abosheasha MA, Fm Z, Mohamed TM. Na+/K+-ATPase activity as a potential biomarker for Type 2 Diabetes mellitus Biochemical invistigation of some natural products on cancer View project. 2018. Available From: https://www.researchgate.net/publication/324825574
[28]
Vehik K, Hamman RF, Lezotte D, Norris JM, Klingensmith GJ, Dabelea D. Childhood growth and age at diagnosis with Type 1 diabetes in Colorado young people. Diabet Med 2009; 26(10): 961-7.
[http://dx.doi.org/10.1111/j.1464-5491.2009.02819.x] [PMID: 19900226]
[29]
Homagai N, Mainali N, Rijal S. Role of positive glucose challenge test only versus oral glucose tolerance test in pregnancy outcome: A comparative study. J Pathol Nepal 2019; 9(2): 1545-9.
[http://dx.doi.org/10.3126/jpn.v9i2.25256]
[30]
Janež A, Guja C, Mitrakou A, et al. Insulin therapy in adults with Type 1 Diabetes Mellitus: A narrative review. Diabetes Ther 2020; 11(2): 387-409.
[http://dx.doi.org/10.1007/s13300-019-00743-7] [PMID: 31902063]
[31]
Tripathi MD. Essentials of Medical Pharmacology. (7th ed.), Gujarat: Jaypee Brothers Medical Pub 2020.
[32]
Kathuria D, Raul AD, Wanjari P, Bharatam PV. Biguanides: Species with versatile therapeutic applications. Eur J Med Chem 2021; 219: 113378.
[http://dx.doi.org/10.1016/j.ejmech.2021.113378] [PMID: 33857729]
[33]
Scheen AJ. Sulphonylureas in the management of type 2 diabetes: To be or not to be? Diabetes Epidemiology and Management 2021; 1: 100002.
[http://dx.doi.org/10.1016/j.deman.2021.100002]
[34]
Landgraf R. Meglitinide analogues in the treatment of type 2 diabetes mellitus. Drugs & Aging 2000; 17: 411-25.
[http://dx.doi.org/10.2165/00002512-200017050-00007]
[35]
Muralidaran S, Roy A. The role of ppar agonists in diabetes mellitus. J Pharm Sci Res 2016; 8(8): 864-6.
[36]
Lebovitz H E. Alpha-glucosidase inhibitors. J Pharm Sci Res 1997; 26(3): 539-51.
[37]
Dipeptidyl Peptidase-4 (DPP-4) Inhibitors. 2022. Available From: https://elsevier.health/en-US/preview/dipeptidyl-peptidase-4-dpp-4-inhibitors
[38]
Modak M, Dixit P, Londhe J, Ghaskadbi S, Paul T, Devasagayam A. Indian herbs and herbal drugs used for the treatment of diabetes. J Clin Biochem Nutr 2007; 40(3): 163-73.
[39]
Maji S. Role of neem leaves in diabetes and obesity Evaluation of antioxidant activity of herbal lassi View project Standardization of methodology for characterization of Panchgavya formulation from Indigenous cows View project. 2020. Available From: https://www.researchgate.net/publication/347833814
[40]
Bharti SK, Krishnan S, Kumar A, Kumar A. Antidiabetic phytoconstituents and their mode of action on metabolic pathways. Ther Adv Endocrinol Metab 2018; 9(3): 81-100.
[http://dx.doi.org/10.1177/2042018818755019] [PMID: 29492244]
[41]
Kumar V. A clinical trial to assess the antidiabetic, antidyslipidemic and antioxidant activities of tinospora cordifolia in management of Type – 2 Diabetes mellitus. Int J Pharm Sci Res 2016; 7(2): 757-64.
[http://dx.doi.org/10.13040/IJPSR.0975-8232.7(2).757-64]
[42]
Bever BO, Zahnd GR. Plants with oral hypoglycemic action. Q J Crude Drug Res 1979; 17(3-4): 139-96.
[http://dx.doi.org/10.3109/13880207909065167]
[43]
Zacharias NT, Sebastian KL, Philip B, Augusti KT. Hypoglycemic and hypolipidaemic effects of garlic in sucrose fed rabbits. Indian J Physiol Pharmacol 1980; 24(2): 151-4.
[PMID: 7380530]
[44]
Khanna P, Jain SC, Panagariya A, Dixit VP. Hypoglycemic activity of polypeptide-p from a plant source. J Nat Prod 1981; 44(6): 648-55.
[http://dx.doi.org/10.1021/np50018a002] [PMID: 7334382]
[45]
Shibib BA, Khan LA, Rahman R. Hypoglycaemic activity of Coccinia indica and Momordica charantia in diabetic rats: Depression of the hepatic gluconeogenic enzymes glucose-6-phosphatase and fructose-1,6-bisphosphatase and elevation of both liver and red-cell shunt enzyme glucose-6-phosphate dehydrogenase. Biochem J 1993; 292(1): 267-70.
[http://dx.doi.org/10.1042/bj2920267] [PMID: 8389127]
[46]
Vats V, Grover JK, Rathi SS. Evaluation of anti-hyperglycemic and hypoglycemic effect of Trigonella foenum-graecum Linn, Ocimum sanctum Linn and Pterocarpus marsupium Linn in normal and alloxanized diabetic rats. J Ethnopharmacol 2002; 79(1): 95-100.
[http://dx.doi.org/10.1016/S0378-8741(01)00374-9] [PMID: 11744301]
[47]
Rai V, Iyer U, Mani UV. Effect of Tulasi (Ocimum sanctum) leaf powder supplementation on blood sugar levels, serum lipids and tissues lipids in diabetic rats. Plant Foods Hum Nutr 1997; 50(1): 9-16.
[http://dx.doi.org/10.1007/BF02436038] [PMID: 9198110]
[48]
Vats V, Yadav SP. Ethanolic extract of Ocimum sanctum leaves partially attenuates streptozotocin induced alteration in glycogen content and carbohydrate metabolism in rats. J Ethnopharmacol 2004; 90(1): 155-60.
[49]
Al-Awadi FM, Gumaa KA. Studies on the activity of individual plants of an antidiabetic plant mixture. Acta Diabetol Lat 1987; 24(1): 37-41.
[http://dx.doi.org/10.1007/BF02732051] [PMID: 3618079]
[50]
Ajabnoor MA. Effect of aloes on blood glucose levels in normal and alloxan diabetic mice. J Ethnopharmacol 1990; 28(2): 215-20.
[http://dx.doi.org/10.1016/0378-8741(90)90031-N] [PMID: 2109811]
[51]
Dubey P, Thakur V, Chattopadhyay M. Role of minerals and trace elements in diabetes and insulin resistance. Nutrients 2020; 12(6): 1864.
[http://dx.doi.org/10.3390/nu12061864] [PMID: 32585827]
[52]
Pivari F, Mingione A, Brasacchio C, Soldati L. Curcumin and type 2 diabetes mellitus: prevention and treatment. Nutrients 2019; 11(8): 1837.
[http://dx.doi.org/10.3390/nu11081837] [PMID: 31398884]
[53]
Xu J, Wang S, Feng T, Chen Y, Yang G. Hypoglycemic and hypolipidemic effects of total saponins from Stauntonia chinensis in diabetic db/db mice. J Cell Mol Med 2018; 22(12): 6026-38.
[http://dx.doi.org/10.1111/jcmm.13876] [PMID: 30324705]
[54]
Ezzo J, Donner T, Nickols D, Cox M. Is Massage useful in the management of diabetes? A systematic review. Diabetes Spectr 2001; 14(4): 218-24.
[55]
Raveendran AV, Deshpandae A, Joshi SR. Therapeutic role of yoga in type 2 diabetes. endocrinol metab 2018; 33(3): 307-17.
[http://dx.doi.org/10.3803/EnM.2018.33.3.307] [PMID: 30112866]
[56]
Bayat D, Mohammadbeigi A, Hashemi M, Mahlooji K. The effect of massage on diabetes and its complications: A systematic review. Crescent J Med Biol Sci 2020; 7(1): 22-8.
[57]
Castro-Sánchez AM, Moreno-Lorenzo C, Matarán-Peñarrocha GA, Feriche-Fernández-Castanys B, Granados-Gámez G, Quesada-Rubio JM. Connective tissue reflex massage for type 2 diabetic patients with peripheral arterial disease: Randomized controlled trial. Evid Based Complement Alternat Med 2011; 2011: 1-12.
[http://dx.doi.org/10.1093/ecam/nep171] [PMID: 19933770]
[58]
Liu M, Chen J, Ren Q, et al. Acupuncture and related techniques for type 2 diabetes mellitus. Medicine 2019; 98(2): e14059.
[http://dx.doi.org/10.1097/MD.0000000000014059] [PMID: 30633207]
[59]
Chen C, Liu J, Sun M, Liu W, Han J, Wang H. Acupuncture for type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials. Complement Ther Clin Pract 2019; 36: 100-12.
[http://dx.doi.org/10.1016/j.ctcp.2019.04.004] [PMID: 31383426]
[60]
Tripathi P, Pandey A, Pandey R, Srivatava R, Goswami S. Alternative therapies useful in the management of diabetes: A systematic review. J Pharm Bioallied Sci 2011; 3(4): 504-12.
[http://dx.doi.org/10.4103/0975-7406.90103] [PMID: 22219583]
[61]
Gandhi GR, Hillary VE, Antony PJ, et al. A systematic review on anti-diabetic plant essential oil compounds: Dietary sources, effects, molecular mechanisms, and safety. Crit Rev Food Sci Nutr 2023; 1-20.
[http://dx.doi.org/10.1080/10408398.2023.2170320] [PMID: 36708221]
[62]
Derosa G, Limas CP, Macías PC, Estrella A, Maffioli P. State of the art papers Dietary and nutraceutical approach to type 2 diabetes. Arch Med Sci 2014; 2(2): 336-44.
[http://dx.doi.org/10.5114/aoms.2014.42587] [PMID: 24904670]
[63]
Ashwlayan VD, Nimesh S. Nutraceuticals in the management of diabetes mellitus. Pharm Pharmacol Int J 2018; 6(2)
[http://dx.doi.org/10.15406/ppij.2018.06.00166]
[64]
Saini A. Devidayal, Verma S, Bhalla AK. Comparative efficacy of once daily insulin glargine with twice daily NPH insulin in children with Type 1 Diabetes. J Diabetes Metab 2011; 2(3)
[http://dx.doi.org/10.4172/2155-6156.1000124]
[65]
Nichol A, Sekar MC. Successful management of extremely insulin-resistant obese diabetic patient with insulin glargine, U-500 regular insulin and pramlintide. J Diabetes Metab 2011; 2(5)
[http://dx.doi.org/10.4172/2155-6156.1000143]
[66]
Abdelkader NF, Eitah HE, Maklad YA, Gamaleldin AA, Badawi MA, Kenawy SA. New combination therapy of gliclazide and quercetin for protection against STZ-induced diabetic rats. Life Sci 2020; 247: 117458.
[http://dx.doi.org/10.1016/j.lfs.2020.117458] [PMID: 32092333]
[67]
Nduka SO, Ajaghaku DL, Sonne MI. Pharmacodynamic herb-drug interactions : The effects of azadirachta indica leaf extracts on two commonly used second generation sulfonylureas. 2015. Available From: www.wjpps.com
[68]
Kaur R, Afzal M, Kazmi I, et al. Polypharmacy (herbal and synthetic drug combination): A novel approach in the treatment of type-2 diabetes and its complications in rats. J Nat Med 2013; 67(3): 662-71.
[http://dx.doi.org/10.1007/s11418-012-0720-5] [PMID: 23151907]
[69]
Gupta RC, Chang D, Nammi S, Bensoussan A, Bilinski K, Roufogalis BD. Interactions between antidiabetic drugs and herbs: An overview of mechanisms of action and clinical implications. Diabetol Metab Syndr 2017; 9(1): 59.
[http://dx.doi.org/10.1186/s13098-017-0254-9] [PMID: 28770011]
[70]
Pathak A, Pathak R. Study of life style habits on risk of type 2 diabetes. Int J Appl Basic Med Res 2012; 2(2): 92-6.
[http://dx.doi.org/10.4103/2229-516X.106349] [PMID: 23776819]
[71]
Patra SR, Jahnavi G. An improvement in compliance for foot care in persons with type 2 diabetes with a teaching session. J Diabetes Metab 2011; 2(4)
[http://dx.doi.org/10.4172/2155-6156.1000130]
[72]
Hussain A, Claussen B, Ramachandran A, Williams R. Prevention of type 2 diabetes: A review. Diabetes Res Clin Pract 2007; 76(3): 317-26.
[http://dx.doi.org/10.1016/j.diabres.2006.09.020] [PMID: 17069920]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy